West Virginia revealed as the state with the highest number of GLP-1 users amidst celebrity usage controversy

Getting your Trinity Audio player ready...
  • West Virginia has the highest number of GLP-1 users, with 24,217.07 GLP-1 prescriptions per 100,000 residents.
  • Kentucky has the second-highest number of users, with 22,003.90 GLP-1 prescriptions per 100,000.
  • Hawaii has the lowest number of users, with 5,050.46 GLP-1 prescriptions per 100,000.

A new study has revealed the states with the highest number of GLP-1 users. GLP-1 drugs include Ozempic, Wegovy, and Mounjaro, and are used by many for weight loss. 

The research, conducted by personal injury lawyers Whitley Law Firm, examined the prescription numbers for GLP-1 prescriptions dispensed in 2024, scaled to local populations to establish a prescription rate per 100,000 residents in each state. 

West Virginia has the highest number of GLP-1 users, with 24,217.07 GLP-1 prescriptions dispensed per 100,000 residents. The number of GLP-1 prescriptions in 2024 reached 428,367, representing a 3.2% decrease from 2023.

Kentucky has the second-highest number of users, with 22,003.90 GLP-1 prescriptions dispensed per 100,000 residents in 2024. 1,009,621 prescriptions were dispensed in 2024, a 2.6% increase from 2023.

In third place is Louisiana, where 20,282.44 GLP-1 prescriptions per 100,000 residents were dispensed in 2024. In this state, a total of 932,543 GLP-1 prescriptions were dispensed, representing an 11.6% decrease.

Ranking fourth is Oklahoma, which recorded 19,504.89 GLP-1 prescriptions dispensed per 100,000 residents. Oklahoma saw a 16.8% increase in the number of GLP-1 prescriptions from 2023-2024, with 798,802 prescriptions dispensed in 2024.

Coming in fifth is Alabama, with 19,260.64 GLP-1 prescriptions dispensed per 100,000 residents. The number of GLP-1 prescriptions in this state rose slightly from 2023, by 0.4%, with a total of 993,406 dispensed in 2024.

Mississippi is in sixth place, with 18,745.96 GLP-1 prescriptions dispensed per 100,000 residents. In this state, the number of GLP-1 prescriptions dispensed in 2024 topped 551,702, an increase of 2.0% from 2023.

Next up is North Dakota, where 17,840.03 GLP-1 prescriptions were dispensed per 100,000 residents. 142,108 GLP-1 prescriptions were dispensed in 2024, representing a 20.8% increase from 2023.

Alaska ranks eighth, with 17,383.09 GLP-1 prescriptions dispensed per 100,000 residents in 2024. In this state, 128,658 GLP-1 prescriptions were dispensed in 2024, representing a 21.8% increase from 2023, the largest increase in this top ten listing.

In ninth place is Arkansas, with 17,346.00 GLP-1 prescriptions dispensed per 100,000 residents. 535,706 prescriptions were dispensed in 2024, a 1.4% decrease from 2023.

Finally, rounding off the top ten is Pennsylvania, with 17,131.12 GLP-1 prescriptions per 100,000 residents dispensed in 2024. 2,240,537 GLP-1 prescriptions were dispensed in 2024, an 8.8% increase from 2023.

On the other end of the scale, Hawaii has the lowest number of GLP-1 users, with 5,050 GLP-1 prescriptions dispensed per 100,000 residents. A total of 73,037 prescriptions were dispensed in 2024, a 21.0% increase from 2023.

The 10 states with the most GLP-1 prescriptions in 2024

 StateGLP-1 Prescriptions Dispensed in 2024 (Per 100,000 Residents)Percentage Change (2023 to 2024)
1West Virginia24,217.07-3.2%
2Kentucky22,003.902.6%
3Louisiana20,282.44-11.6%
4Oklahoma19,504.8916.8%
5Alabama19,260.640.4%
6Mississippi18,745.962.0%
7North Dakota17,840.0320.8%
8Alaska17,383.0921.8%
9Arkansas17,346.00-1.4%
10Pennsylvania17,131.128.8%

Commenting on the study, a spokesperson from Whitley Law Firm said: 

“It’s interesting to see the varying rates of GLP-1 prescriptions across the U.S., highlighting the states where medications like Ozempic are most commonly used. With West Virginia leading the rankings, the differences may be due to a range of factors, including healthcare access, lifestyle, and medical needs.

“As the conversation around GLP-1 medications continues, it’s important to consider the factors driving these trends. Understanding these patterns can help inform future discussions on public health and medical accessibility.”

-ENDS-

If you use this story, please credit and link to https://whitleylawfirm.com. A linked credit allows us to keep supplying you with future content that you may find useful.

Sourceswww.axios.com

Methodology:

Axios provides prescription numbers for GLP-1 drugs dispensed in 2024, divided by state (https://www.axios.com/local/nw-arkansas/2025/01/09/mapped-weight-loss-drugs). This data is pulled from the Purple Labs prescription database.

Full state ranking 

 StateGLP-1 Prescriptions Dispensed in 2024 (Per 100,000 Residents)Percentage Change (2023 to 2024)
1West Virginia24,217.07-3.20%
2Kentucky22,003.902.60%
3Louisiana20,282.44-11.60%
4Oklahoma19,504.8916.80%
5Alabama19,260.640.40%
6Mississippi18,745.962.00%
7North Dakota17,840.0320.80%
8Alaska17,383.0921.80%
9Arkansas17,346.00-1.40%
10Pennsylvania17,131.128.80%
11Iowa16,266.0214.40%
12Michigan15,780.565.40%
13Kansas15,320.657.40%
14Georgia15,249.5311.10%
15Texas14,908.074.80%
16Tennessee14,893.814.20%
17Idaho14,439.86-10.90%
18Ohio14,255.936.90%
19New York14,196.8315.10%
20New Jersey14,049.3335.80%
21Missouri13,967.837.20%
22South Carolina13,613.059.30%
23Nebraska13,560.409.00%
24Connecticut13,129.4912.70%
25Illinois12,892.0613.80%
26Maine12,720.5327.20%
27Indiana12,699.190.80%
28North Carolina12,334.495.70%
29Wyoming12,242.9917.10%
30New Mexico12,217.3120.40%
31Virginia11,687.539.00%
32Vermont11,516.08-1.70%
33Minnesota11,440.5813.00%
34New Hampshire11,281.0115.30%
35Montana11,094.917.30%
36Massachusetts10,892.7048.00%
37South Dakota10,872.32-11.10%
38Delaware10,846.964.70%
39Florida10,390.4123.70%
40Wisconsin9,978.3221.80%
41Maryland9,644.9122.60%
42California9,462.745.40%
43Washington9,015.308.40%
44Utah8,536.166.20%
45Arizona8,100.0112.60%
46Oregon7,920.3612.60%
47Colorado7,795.2917.20%
48Rhode Island7,501.1667.80%
49Nevada7,431.115.10%
50Hawaii5,050.4621.00%

If you appreciate BBG's work, please support us with a contribution of whatever you can afford.

Support our stories

Author